Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiopharmaceuticals | 9 | 2023 | 55 | 1.950 |
Why?
|
| Technetium | 5 | 2018 | 11 | 1.910 |
Why?
|
| Chelating Agents | 7 | 2023 | 57 | 1.860 |
Why?
|
| Lanthanoid Series Elements | 7 | 2011 | 8 | 1.660 |
Why?
|
| Oligopeptides | 4 | 2018 | 102 | 1.540 |
Why?
|
| Rhenium | 4 | 2018 | 12 | 1.510 |
Why?
|
| Pyridones | 4 | 2023 | 40 | 1.370 |
Why?
|
| Tungsten Compounds | 12 | 2016 | 15 | 1.280 |
Why?
|
| Coordination Complexes | 5 | 2019 | 28 | 1.260 |
Why?
|
| Radioisotopes | 6 | 2020 | 16 | 1.230 |
Why?
|
| Zirconium | 3 | 2015 | 9 | 1.130 |
Why?
|
| Alpha Particles | 3 | 2020 | 4 | 1.070 |
Why?
|
| Positron-Emission Tomography | 6 | 2023 | 80 | 0.870 |
Why?
|
| Europium | 5 | 2011 | 9 | 0.870 |
Why?
|
| Organotechnetium Compounds | 6 | 2007 | 9 | 0.790 |
Why?
|
| Radiochemistry | 5 | 2020 | 6 | 0.780 |
Why?
|
| Oxides | 2 | 2012 | 89 | 0.760 |
Why?
|
| Actinium | 1 | 2020 | 1 | 0.760 |
Why?
|
| Magnetic Resonance Spectroscopy | 13 | 2016 | 289 | 0.750 |
Why?
|
| Tissue Distribution | 10 | 2018 | 207 | 0.670 |
Why?
|
| Mice, Nude | 6 | 2018 | 337 | 0.660 |
Why?
|
| Spermine | 2 | 2019 | 64 | 0.630 |
Why?
|
| Neoplasms | 3 | 2020 | 1103 | 0.600 |
Why?
|
| Immunoconjugates | 1 | 2015 | 7 | 0.540 |
Why?
|
| Deferoxamine | 1 | 2015 | 19 | 0.540 |
Why?
|
| Electrons | 2 | 2012 | 68 | 0.500 |
Why?
|
| Breast | 1 | 2015 | 135 | 0.490 |
Why?
|
| Holmium | 1 | 2013 | 1 | 0.480 |
Why?
|
| Radioimmunotherapy | 1 | 2013 | 2 | 0.480 |
Why?
|
| Melanoma, Experimental | 1 | 2013 | 9 | 0.470 |
Why?
|
| Acetonitriles | 2 | 2011 | 10 | 0.470 |
Why?
|
| Models, Molecular | 9 | 2016 | 808 | 0.460 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 290 | 0.410 |
Why?
|
| Sodium Pertechnetate Tc 99m | 1 | 2011 | 1 | 0.410 |
Why?
|
| Molecular Structure | 8 | 2019 | 492 | 0.400 |
Why?
|
| Melanins | 1 | 2011 | 36 | 0.390 |
Why?
|
| Light | 2 | 2011 | 187 | 0.390 |
Why?
|
| Animals | 18 | 2023 | 15081 | 0.380 |
Why?
|
| Melanoma | 1 | 2011 | 96 | 0.370 |
Why?
|
| Crystallography, X-Ray | 8 | 2007 | 265 | 0.360 |
Why?
|
| Mice | 8 | 2023 | 5913 | 0.340 |
Why?
|
| Isotope Labeling | 6 | 2018 | 26 | 0.340 |
Why?
|
| Metal Nanoparticles | 1 | 2011 | 183 | 0.330 |
Why?
|
| Ligands | 6 | 2023 | 349 | 0.320 |
Why?
|
| Oxidation-Reduction | 5 | 2012 | 431 | 0.310 |
Why?
|
| Receptors, Somatostatin | 1 | 2007 | 5 | 0.310 |
Why?
|
| Somatostatin | 1 | 2007 | 22 | 0.300 |
Why?
|
| Oxygen | 1 | 2007 | 207 | 0.280 |
Why?
|
| Technetium Compounds | 2 | 2016 | 3 | 0.270 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 2231 | 0.260 |
Why?
|
| Amino Acid Sequence | 3 | 2018 | 1180 | 0.260 |
Why?
|
| Molecular Conformation | 7 | 2016 | 152 | 0.260 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 1502 | 0.240 |
Why?
|
| Peptides, Cyclic | 1 | 2004 | 29 | 0.240 |
Why?
|
| Drug Stability | 2 | 2014 | 116 | 0.230 |
Why?
|
| Vanadium | 3 | 2016 | 6 | 0.230 |
Why?
|
| Electrochemistry | 3 | 2012 | 34 | 0.230 |
Why?
|
| Female | 11 | 2018 | 20969 | 0.220 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2020 | 364 | 0.210 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2019 | 16 | 0.210 |
Why?
|
| Radionuclide Imaging | 5 | 2011 | 28 | 0.210 |
Why?
|
| Peptides | 1 | 2004 | 320 | 0.190 |
Why?
|
| Thorium | 1 | 2020 | 1 | 0.190 |
Why?
|
| Pistacia | 1 | 2020 | 3 | 0.180 |
Why?
|
| Radiation Monitoring | 1 | 2020 | 7 | 0.180 |
Why?
|
| Transition Elements | 1 | 2019 | 3 | 0.180 |
Why?
|
| Solvents | 2 | 2010 | 99 | 0.170 |
Why?
|
| Stereoisomerism | 3 | 2007 | 167 | 0.160 |
Why?
|
| Polymers | 3 | 2008 | 121 | 0.160 |
Why?
|
| Water | 4 | 2011 | 296 | 0.150 |
Why?
|
| Cyclooctanes | 1 | 2016 | 1 | 0.140 |
Why?
|
| Lutetium | 1 | 2016 | 2 | 0.140 |
Why?
|
| Humans | 14 | 2020 | 37093 | 0.140 |
Why?
|
| Anions | 4 | 2010 | 39 | 0.140 |
Why?
|
| Phosphorus Isotopes | 5 | 2007 | 8 | 0.140 |
Why?
|
| Tetrazoles | 1 | 2016 | 49 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2016 | 86 | 0.140 |
Why?
|
| Isomerism | 2 | 2016 | 63 | 0.130 |
Why?
|
| Emollients | 1 | 2015 | 1 | 0.130 |
Why?
|
| Skin Diseases | 1 | 2015 | 31 | 0.130 |
Why?
|
| Benzyl Compounds | 1 | 1994 | 3 | 0.130 |
Why?
|
| X-Ray Absorption Spectroscopy | 2 | 2013 | 7 | 0.120 |
Why?
|
| Methane | 1 | 2014 | 7 | 0.120 |
Why?
|
| Pentetic Acid | 1 | 2013 | 4 | 0.120 |
Why?
|
| Yttrium Radioisotopes | 1 | 2013 | 4 | 0.120 |
Why?
|
| Half-Life | 1 | 2013 | 54 | 0.120 |
Why?
|
| Photochemistry | 2 | 2011 | 63 | 0.120 |
Why?
|
| Imidazoles | 1 | 2014 | 126 | 0.110 |
Why?
|
| Sulfuric Acids | 1 | 2013 | 4 | 0.110 |
Why?
|
| Methanol | 1 | 2013 | 18 | 0.110 |
Why?
|
| Radioactive Waste | 1 | 2012 | 4 | 0.110 |
Why?
|
| Chemistry, Physical | 3 | 2008 | 45 | 0.110 |
Why?
|
| Quantum Theory | 1 | 2012 | 78 | 0.100 |
Why?
|
| Thermodynamics | 1 | 2012 | 216 | 0.100 |
Why?
|
| Phenanthrolines | 1 | 2011 | 4 | 0.100 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2011 | 34 | 0.100 |
Why?
|
| Amines | 1 | 2011 | 39 | 0.100 |
Why?
|
| Salts | 1 | 2010 | 16 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 259 | 0.090 |
Why?
|
| Electrochemical Techniques | 1 | 2010 | 22 | 0.090 |
Why?
|
| Solutions | 1 | 2010 | 62 | 0.090 |
Why?
|
| Ions | 1 | 2010 | 61 | 0.090 |
Why?
|
| Pyridines | 1 | 2011 | 116 | 0.090 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 208 | 0.090 |
Why?
|
| Radioligand Assay | 2 | 2007 | 66 | 0.090 |
Why?
|
| Chemical Phenomena | 3 | 2002 | 54 | 0.090 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 202 | 0.090 |
Why?
|
| Luminescence | 3 | 2005 | 24 | 0.080 |
Why?
|
| Organometallic Compounds | 2 | 2007 | 73 | 0.080 |
Why?
|
| Yttrium | 1 | 2008 | 3 | 0.080 |
Why?
|
| Silicon Compounds | 1 | 2008 | 6 | 0.080 |
Why?
|
| Porphyrins | 2 | 2008 | 55 | 0.080 |
Why?
|
| Rats | 6 | 2007 | 3483 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2004 | 421 | 0.080 |
Why?
|
| Magnetics | 1 | 2007 | 36 | 0.080 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2007 | 39 | 0.080 |
Why?
|
| Circular Dichroism | 1 | 2007 | 62 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 122 | 0.070 |
Why?
|
| Rubella | 1 | 1986 | 15 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2007 | 111 | 0.070 |
Why?
|
| Silicon Dioxide | 1 | 2005 | 34 | 0.070 |
Why?
|
| Spectrophotometry, Infrared | 3 | 2006 | 37 | 0.070 |
Why?
|
| Adsorption | 2 | 2020 | 68 | 0.060 |
Why?
|
| Phosphotungstic Acid | 1 | 2004 | 1 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1986 | 103 | 0.060 |
Why?
|
| Models, Biological | 1 | 2007 | 677 | 0.060 |
Why?
|
| Kinetics | 2 | 2020 | 708 | 0.060 |
Why?
|
| Chromans | 1 | 2001 | 15 | 0.050 |
Why?
|
| Pyrrolidines | 1 | 2001 | 29 | 0.050 |
Why?
|
| Structure-Activity Relationship | 3 | 2016 | 409 | 0.050 |
Why?
|
| Piperidines | 1 | 2001 | 77 | 0.050 |
Why?
|
| Metals, Rare Earth | 1 | 2001 | 3 | 0.050 |
Why?
|
| Solubility | 3 | 2006 | 118 | 0.050 |
Why?
|
| Nicotinic Agonists | 1 | 2001 | 75 | 0.050 |
Why?
|
| Uranium | 1 | 2020 | 21 | 0.040 |
Why?
|
| X-Ray Diffraction | 3 | 2005 | 57 | 0.040 |
Why?
|
| Seawater | 1 | 2020 | 45 | 0.040 |
Why?
|
| Heart | 2 | 1992 | 180 | 0.040 |
Why?
|
| Beta Particles | 1 | 2018 | 2 | 0.040 |
Why?
|
| Anisotropy | 2 | 2007 | 27 | 0.030 |
Why?
|
| Mineral Oil | 1 | 2015 | 1 | 0.030 |
Why?
|
| Pruritus | 1 | 2015 | 3 | 0.030 |
Why?
|
| Petrolatum | 1 | 2015 | 2 | 0.030 |
Why?
|
| Erythema | 1 | 2015 | 10 | 0.030 |
Why?
|
| Cations | 2 | 2006 | 45 | 0.030 |
Why?
|
| Glycerol | 1 | 2015 | 28 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2005 | 68 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 661 | 0.030 |
Why?
|
| Dicarboxylic Acids | 1 | 1993 | 1 | 0.030 |
Why?
|
| Diamide | 1 | 1993 | 2 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1039 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 1993 | 47 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 610 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1994 | 1618 | 0.030 |
Why?
|
| Male | 7 | 2015 | 20025 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 2379 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1369 | 0.020 |
Why?
|
| Piperazines | 1 | 1992 | 111 | 0.020 |
Why?
|
| Gallium Radioisotopes | 1 | 1990 | 2 | 0.020 |
Why?
|
| Italy | 2 | 1989 | 22 | 0.020 |
Why?
|
| Fibroma | 1 | 1988 | 4 | 0.020 |
Why?
|
| Mesentery | 1 | 1988 | 9 | 0.020 |
Why?
|
| Pharmaceutical Solutions | 1 | 2008 | 5 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 1988 | 16 | 0.020 |
Why?
|
| Absorption | 1 | 2008 | 25 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 26 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2008 | 47 | 0.020 |
Why?
|
| Temperature | 2 | 2008 | 286 | 0.020 |
Why?
|
| Lasers | 1 | 2008 | 65 | 0.020 |
Why?
|
| Static Electricity | 1 | 2008 | 78 | 0.020 |
Why?
|
| Rubella Vaccine | 1 | 1986 | 2 | 0.020 |
Why?
|
| Brain | 1 | 1994 | 1346 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 1986 | 49 | 0.020 |
Why?
|
| Immune System | 1 | 1986 | 41 | 0.020 |
Why?
|
| Aluminum Silicates | 1 | 2005 | 6 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2005 | 50 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2005 | 58 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2005 | 60 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 103 | 0.020 |
Why?
|
| Aged | 2 | 2015 | 6741 | 0.020 |
Why?
|
| Surface Properties | 1 | 2005 | 130 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 1986 | 155 | 0.020 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2005 | 88 | 0.020 |
Why?
|
| Middle Aged | 3 | 2015 | 10129 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 562 | 0.010 |
Why?
|
| Drug Design | 1 | 2005 | 162 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 1989 | 441 | 0.010 |
Why?
|
| Synaptosomes | 1 | 2001 | 21 | 0.010 |
Why?
|
| Macaca fascicularis | 2 | 1993 | 64 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2001 | 73 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2001 | 73 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 133 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 2001 | 70 | 0.010 |
Why?
|
| Oocytes | 1 | 2001 | 146 | 0.010 |
Why?
|
| Pregnancy | 1 | 1986 | 1549 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 325 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 2001 | 106 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2001 | 104 | 0.010 |
Why?
|
| Dopamine | 1 | 2001 | 245 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 290 | 0.010 |
Why?
|
| Nicotine | 1 | 2001 | 257 | 0.010 |
Why?
|
| Adolescent | 1 | 1986 | 5363 | 0.010 |
Why?
|
| Adult | 2 | 1989 | 11712 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1993 | 66 | 0.010 |
Why?
|
| Perfusion | 1 | 1992 | 33 | 0.010 |
Why?
|
| Sulfur | 1 | 1992 | 18 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1992 | 53 | 0.010 |
Why?
|
| Nitrogen | 1 | 1992 | 71 | 0.010 |
Why?
|
| Cysteamine | 1 | 1990 | 3 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1990 | 7 | 0.010 |
Why?
|
| Kidney | 1 | 1993 | 337 | 0.010 |
Why?
|
| Radiography | 1 | 1989 | 72 | 0.010 |
Why?
|
| Occult Blood | 1 | 1989 | 29 | 0.010 |
Why?
|
| Biopsy | 1 | 1989 | 164 | 0.010 |
Why?
|
| Colonoscopy | 1 | 1989 | 104 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1989 | 275 | 0.000 |
Why?
|
| Colon | 1 | 1989 | 103 | 0.000 |
Why?
|
| Fibrosis | 1 | 1988 | 159 | 0.000 |
Why?
|
| Mass Screening | 1 | 1989 | 462 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1989 | 2026 | 0.000 |
Why?
|
| Risk Factors | 1 | 1989 | 3562 | 0.000 |
Why?
|
| Chemistry | 1 | 1972 | 17 | 0.000 |
Why?
|